A recently cloned neurotrophic factor, termed glial cell line-derived
neurotrophic factor (GDNF), has been reported to exhibit selective neu
rotrophic properties on ventral mesencephalon dopaminergic neurons, wh
ich degenerate in patients with Parkinson's disease. In the present st
udy, we used reverse transcriptase followed by polymerase chain reacti
on (PCR) and in situ hybridization to study the expression of GDNF mes
senger RNA (mRNA) in the adult rat and human central nervous system (C
NS). GDNF transcripts were identified using PCR in all regions of the
rat CNS analyzed including striatum, hippocampus, cortex, cerebellum,
and spinal cord. Interestingly, the rat hippocampal formation containe
d two transcripts, i.e., a larger form in addition to the amplified GD
NF cDNA found in all other areas analyzed. GDNF PCR products also were
observed in human striatum, hippocampus, cortex, and spinal cord, but
not cerebellum, and both the striatum and hippocampal formation conta
ined two GDNF transcripts. Finally, G;DNF transcripts were detected in
a rat Schwann cell line previously shown to secrete a factor that exe
rts a neurotrophic effect on dopaminergic neurons. In situ hybridizati
on experiments using a cRNA probe hybridized to adult rat brain sectio
ns demonstrated no positive GDNF mRNA signal. However, intense GDNF mR
NA hybridization signal was found to be associated with dorsal root ga
nglia in Postnatal Day 1 rats. These findings provide evidence that GD
NF is detectable using PCR in a number of nervous system structures an
d, in some areas, GDNF is expressed in more than one form. (C) 1994 Ac
ademic Press, Inc.